European Pharmaceutical Review

MAY 18, 2023

A new document published by European Medicines Agency (EMA) makes ten recommendations and outlines good practices “to ensure continuity in the supply of human medicines, prevent shortages and reduce their impact.” Medicine shortages are a global health problem and are increasingly affecting European countries, according to EMA.

Medicine 89

Medicine Distribution Manufacturing Management 89

European Pharmaceutical Review

FEBRUARY 21, 2023

The UK medicinal cannabis sector has witnessed important regulatory advances in recent years. In this Q&A, EPR caught up with CEO James Short and Managing Director Arthur Wakeley from Celadon, to learn more about the company’s experience moving through, and progressing, the strict regulatory process for medicinal cannabis.

Medicine 128

Medicine Manufacturing Specialization Pharmaceutical 128

pharmaphorum

OCTOBER 28, 2022

In June, NHSE and NICE published details on the Innovative Medicines Fund, which will help improve patient access to cutting-edge medicines, with a particular focus on rare diseases, and ensure global pharmaceutical and biotech organisations continue to prioritise the UK as a launch destination. Angela McFarlane ?,

Medicine 110

Medicine Management Marketing Leads 110

MedCity News

JULY 12, 2023

That’s why I left traditional medicine. Providers just aren’t given the time it takes to build rapport and ask the right questions within the fee-for-service model. Providers like me who now work in an employer healthcare model can truly help people versus treating them reactively.

Healthcare 85

Healthcare Healthcare Leads Patients 85

MedCity News

SEPTEMBER 20, 2023

This accelerates lead identification and optimization, offering researchers a broader pool of candidates to choose from. Generative AI plays a pivotal role by analyzing genetic, physiological, and clinical data to tailor treatments to individual patients.

Ethics 111

Ethics Medicine Pharmaceutical Pharmaceutical research 111

Salesforce

FEBRUARY 20, 2024

I downloaded TikTok and Instagram and started making ridiculous videos about living life with a disability, about being a young face of ALS, about the disgusting taste of my medicine — anything I could do to get people googling ALS and learning more.” Patient advocacy in life sciences is becoming increasingly important as a result of this.

Patients 137

Patients Pharma Consulting Leads 137

European Pharmaceutical Review

JANUARY 11, 2024

What are the key current challenges in the development of pain medicines? What is the present clinical landscape for pain management medicines, especially chronic pain? Pain management therapies: Pfizer’s migraine medicine recommended by NICE What are three current development trends for pain management treatments?

Medicine 78

Medicine Pharmacology Management Side effects 78

World of DTC Marketing

MARCH 28, 2021

IN BRIEF: Doctors are not required to treat obese patients who won’t do anything to lose weight but the problem is more than reminding patients they need to get exercise and drop pounds. This is leading to excessive costs to out healthcare system and something needs to be done. This is going to cost us ALL.

Doctors 250

Doctors Patients Insurance Physicians 250

pharmaphorum

OCTOBER 12, 2022

Now, he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies – an emerging field in which genetic sequences are injected into cells to target and repair damaged genes. The evolving field of genomic medicine. This is just the beginning; the potential is enormous,” he says.

Medicine 90

Medicine Patients Healthcare Healthcare 90

World of DTC Marketing

MARCH 23, 2022

Do patients care? Do patients care? If you’re a cancer patient and your oncologist is prescribing a drug approved via accelerated Approval, are you going to refuse treatment? Should patients be made aware that the drug they are being prescribed is an “accelerated approval drug”? Of course not.

Patients 200

Patients FDA Doctors Physicians 200

PM360

SEPTEMBER 7, 2023

The New England Journal of Medicine runs a weekly diagnostic challenge tasking physicians with correctly identifying a thorny case. AI and the Future Patient Experience Even though marketers should not forget about the people behind medical care, they still can’t ignore the potential of AI to transform the patient experience.

Patients 111

Patients Physicians Healthcare Healthcare 111

pharmaphorum

NOVEMBER 18, 2022

Gene-testing specialist Editas Medicine has halted development of its lead clinical programme for congenital eye disorders after it generated lacklustre results in a phase 1/2 trial. The post After disappointing trial, Editas puts lead CRISPR drug up for sale appeared first on.

Leads 92

Leads Sales Medicine Patients 92

Pharmaceutical Technology

DECEMBER 23, 2022

Eli Lilly and Company has expanded a licencing and partnership agreement with ProQR Therapeutics to discover, develop and market new genetic medicines. The post Lilly and ProQR to expand genetic medicine development agreement appeared first on Pharmaceutical Technology. Optimise your cell therapy process: a guide to cell thawing.

Medicine 131

Medicine Pharmaceutical Marketing Sales 131

pharmaphorum

OCTOBER 12, 2022

The Eureka Institute, a Syracuse, Italy-based non-profit, is focused on addressing this disparity by providing education, research, and advocacy around the field of translational medicine. The group will be leading a workshop on the topic at Frontiers Health next week. Translational medicine and digital health.

Medicine 101

Medicine Training Education Healthcare 101

Pharmaceutical Technology

JUNE 20, 2023

The Department of Health Abu Dhabi (DoH) has signed a memorandum of understanding with integrated healthcare company M42 and AbbVie Biopharmaceuticals to advance personalised medicine and genomics in the city. M42 was created through the combination of Mubadala Health and G42 Healthcare.

Medicine 52

Medicine Healthcare Healthcare Patients 52

Healthcare Success

MAY 9, 2022

The QR code allows hospitals and healthcare providers to satisfy this need with immediate physician-patient interaction and engagement – all through smartphones and tablets. . In this blog post, you’ll learn: Why QR codes have made a comeback, When to use them, And, 8 ways to improve the patient experience and drive leads with QR codes. .

Leads 52

Leads Patients Healthcare Provider Healthcare 52

European Pharmaceutical Review

OCTOBER 20, 2022

Apogenix , a biopharmaceutical company developing next generation immunotherapeutics, announced that asunercept showed statistically significant benefits for hospitalised COVID-19 patients in the ASUNCTIS trial. The Phase II trial investigated efficacy and safety of asunercept in 435 patients with moderate to severe COVID-19 disease.

Patients 99

Patients Safety Medicine Leads 99

PM360

JULY 13, 2023

“People adhere to medicines at a scale that should bewilder everyone in healthcare,” exclaims Grace Lomax, Clinical Director of Patient Connect , part of Clarivate. Little wonder 70% of patients with hypertension remain hypertensive and therefore at risk of myocardial infarctions (MIs) and cerebrovascular accidents.

Patients 98

Patients Education Medical Side effects 98

European Pharmaceutical Review

OCTOBER 20, 2022

City of Hope , one of the largest cancer research and treatment organisations in the US, announced that the first patient to receive novel cancer medicine AOH1996, is doing well. Its objective is to determine the maximum tolerated dose of the investigational pill, AOH1996, and to evaluate the medicine for preliminary efficacy.

Patients 95

Patients Medicine Safety Medical 95

European Pharmaceutical Review

MAY 2, 2023

Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. 3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. 1,2 In the EU, an estimated 2.7

Patients 99

Patients Medicine Marketing Medical 99

Pharmaceutical Technology

AUGUST 11, 2022

Gemini Therapeutics has signed a definitive agreement to merge with Disc Medicine in an all-stock deal to create a clinical-stage biopharmaceutical company. The merged company is expected to be named Disc Medicine, which will have corporate headquarters in Watertown, Massachusetts, US. To back the merger, Disc raised funds worth $53.5m

Medicine 59

Medicine Transportation Patients Healthcare 59

Pharmaceutical Technology

NOVEMBER 1, 2022

Intrinsic Medicine has signed a definitive business combination agreement with special purpose acquisition (SPAC) firm Phoenix Biotech Acquisition to create a public company. To be named Intrinsic Medicine following closing, the combined company will be led by current Intrinsic CEO Alexander Martinez and president and COO Jason Ferrone.

Medicine 59

Medicine Safety Specialization Leads 59

Pharmaceutical Technology

JULY 1, 2022

Blueprint Medicines has entered strategic financing partnerships for up to $1.25bn with life sciences-focused investors Sixth Street and Royalty Pharma. Under the deal, Blueprint Medicines will receive an upfront cash payment of $175m as well as up to $165m in potential milestone payments contingent on sales in the future.

Medicine 59

Medicine Food and Drug Administration FDA Prospecting 59

Copyright Clearance Center

AUGUST 9, 2022

The JAMA Network brings JAMA together with JAMA Network Open and 11 specialty medical journals to offer enhanced access to the research, reviews, and opinions shaping the future of medicine. NEJM is recognized as the world’s leading medical journal and website.

Networking 116

Networking Medicine Physicians Education 116

Pharmaceutical Technology

JANUARY 4, 2023

Belharra Therapeutics and Roche Group member Genentech have announced a partnership for the discovery and development of new small molecule medicines across several therapeutic areas. The post Belharra and Genentech partner for small molecule medicines development appeared first on Pharmaceutical Technology.

Medicine 52

Medicine Sales Leads Pharmaceutical 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time.

Specialization 45

Specialization Leads Pharma Side effects 45

European Pharmaceutical Review

MARCH 8, 2023

Ekaterina received her medical degree from St Petersburg Medical Academy in St Petersburg, Russia, and then moved to the US where she completed her Internal Medicine residency training. She worked in private practice, academic medicine and public health for more than 15 years in the greater New York area.

Leads 52

Leads Pharma Food and Drug Administration Medicine 52

Pharmaceutical Technology

APRIL 27, 2023

Orbital will use the new funding to increase the application of RNA-based medicines for use in the fields of new vaccines, immunomodulation and protein replacement. New investors included the Redmile Group, the Abu Dhabi Growth Fund (ADG), Exor, Invus, Moore Strategic Ventures, the iGlobe Platinum Fund Group and Casdin Capital.

Medicine 52

Medicine Leads Patients Pharmaceutical 52

Pharmaceutical Technology

SEPTEMBER 8, 2022

Pharmaceutical compounding is a method of preparing personalised medications for patients by mixing the individual ingredients in the exact strength and dosage form required by the patient. Pharmaceutical compounding may fulfil the specific requirements of patients, unlike mass-produced medicines. Excipients. Formulation.

Leads 52

Leads Pharmaceutical Marketing Medicine 52

PM360

JUNE 11, 2022

What is the value of a patient-centric approach if that approach doesn’t include the patients themselves? They want a patient inclusive approach. More specifically, what role is Medical Affairs playing in working with patients to create educational materials that would make sense to fellow patients?

Patients 98

Patients Medical Education Government 98

pharmaphorum

JANUARY 27, 2023

Having previously spoken with Dr Mullen three years ago when she was country medical director for the UK & Ireland at GSK – on the topic of patient centricity and embedding that focus within the core of a pharmaceutical company – our recent interview provided some interesting insights into the changing landscape of the industry.

Patients 95

Patients Pharmaceutical Medical Physicians 95

Pharmaceutical Technology

OCTOBER 11, 2022

Swiss biotech company Stalicla has signed a licensing deal with Evgen Pharma for the latter’s lead asset, SFX-01, in neurodevelopmental disorders and schizophrenia. It is claimed to be the only grade of sulforaphane which is suitable for clinical research and will eventually be approved as a medicine.

Leads 59

Leads Food and Drug Administration Food Medicine 59

Clarivate

AUGUST 2, 2022

Four major trends came to light from CIRS’ most recent analysis of new active substance (NAS) approvals for the European Medicines Agency (EMA), US Food and Drug Administration (FDA), Japanese Pharmaceuticals and Medical Devices Agency (PMDA), Health Canada, Swissmedic and the Australian Therapeutic Goods Administration (TGA).

Medicine 98

Medicine Food and Drug Administration FDA Healthcare 98

pharmaphorum

DECEMBER 1, 2022

Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.

Patients 103

Patients Transportation Retail Recruitment 103

pharmaphorum

JULY 15, 2022

Akili looks like it could bring another digital therapeutic (DTx) to market after a clinical trial backed the efficacy of its AKL-T01 in patients with the autoimmune disorder systemic lupus erythematosus (SLE). million people in the US are living with SLE.

Patients 104

Patients Engineering Marketing Medical 104

European Pharmaceutical Review

SEPTEMBER 20, 2022

The European Commission has approved Roche’s Vabysmo ® (faricimab) for the treatment of neovascular or ‘wet’ age-related macular degeneration (nAMD) and visual impairment due to diabetic macular oedema (DME) – two of the leading causes of vision loss worldwide. About diabetic macular oedema.

Leads 76

Leads Engineering Physicians Medicine 76

European Pharmaceutical Review

MAY 29, 2023

A neurosteroid drug was one of two medicines recommended for approval at the Committee for Medicinal Products for Human Use (CHMP) ’s May 2023 meeting. This medicinal product has potential to diagnose this cancer in high risk patients in early stages and for patients with suspected recurrence.

Medicine 90

Medicine Marketing Safety Leads 90